Genetic Study Reveals Women Face Higher Depression Risk Due to DNA Factors

A major Australian study has revealed that genetic factors play a far greater role in depression risk among females than males, shedding new light on why women are more prone to the condition. Conducted by scientists at the QIMR Berghofer Medical Research Institute in Brisbane, the research analyzed DNA samples from nearly half a million people and was published in the journal Nature Communications.

The study found nearly twice as many genetic markers linked to depression in females compared to males. According to Dr. Brittany Mitchell, the lead researcher, this finding provides valuable insight into long-standing questions about the biological and genetic differences that influence mental health. “We already know that females are twice as likely to suffer from depression in their lifetime than males,” Dr. Mitchell said. “Until now, there hasn’t been much consistent research to explain why depression affects females and males differently, especially in terms of genetics.”

Researchers identified about 7,000 DNA variations associated with depression in both sexes and around 6,000 additional variations that appeared to affect females only. These sex-specific genetic factors may help explain why women often report more frequent and severe symptoms of depression. The study also discovered that the genetic components linked to depression overlap more strongly with genes responsible for metabolic traits in females than in males. This could clarify why women with depression more commonly experience changes in weight, appetite, and energy levels compared to men.

The findings suggest that biological differences, particularly in how genes interact with hormonal and metabolic systems, may play a crucial role in shaping the experience of depression between men and women. Researchers believe this deeper understanding could eventually lead to more personalized treatment approaches that account for sex-based genetic differences.

One major concern raised by the study is that most antidepressant drug trials and clinical research have traditionally been conducted on male participants, potentially limiting the effectiveness of treatments for females. “These findings underscore the importance of considering sex-specific genetic factors in the study of health conditions, including major depressive disorder,” the researchers said. They hope that these insights will pave the way for more targeted treatment strategies that better address the needs of women suffering from depression.

In addition to the genetic findings, a separate study presented at the United European Gastroenterology Week in Berlin revealed another concerning health risk: microplastics in the human digestive system. Scientists reported that these tiny plastic particles, often ingested through contaminated food and water, can alter the population of healthy bacteria in the gut—known as the gut microbiome. Laboratory experiments showed that microplastics disrupted the balance of beneficial microbes in ways similar to changes observed in people with depression, colorectal cancer, and other diseases.

These new findings highlight how environmental and biological factors can interact to influence both physical and mental health. Together, the studies point toward a growing need for a more holistic understanding of how genetics, lifestyle, and environmental exposure shape human wellbeing. As research continues, scientists hope such insights will guide the development of treatments that are not only more effective but also tailored to the unique biological makeup of each individual.